Specialties

T2T approach in women with RA can increase fertility

Presented By

Prof. Radboud Dolhain, Erasmus University Medical Center, the Netherlands

Trial

PARA, PreCARA

Conference

ACR 2024

Type

News article

19 November 2024 11:27

Post-hoc analysis of 3 large trials maps sex differences in PsA

Presented By

Dr Laura Coates, University of Oxford, UK

Trial

DISCOVER-1, DISCOVER-2, COSMOS

Conference

ACR 2024

Type

News article

19 November 2024 11:25

Registry participation can enhance quality of rheumatology care

Presented By

Dr Gabriela Schmajuk, University of California, San Francisco, CA, USA

Conference

ACR 2024

Type

News article

19 November 2024 11:23

PsoBest registry: Biologics dominate treatment for moderate-to-severe psoriasis

Presented By

Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany

Trial

PsoBest registry

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:23

Advanced therapies show promising results in PsA real-world study

Presented By

Prof. Dennis McGonagle, University of Leeds, UK

Trial

PRO-SPIRIT

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

Small protein targeting IL-17A effective in PsA management

Presented By

Prof. Philip Mease, University of Washington; Swedish Medical Center, WA, USA

Trial

Phase 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

New JAK1 inhibitor outperforms placebo in active RA

Presented By

Dr Jinjing Liu, Peking Union Medical College Hospital, China

Trial

Phase 3

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:37

Macrophage profiling in synovial tissue predicts treatment response in RA

Presented By

Dr Simone Perniola, Policlinico Universitario A. Gemelli IRCS, Italy

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:36

Innovative app boosts mental health in patients with RA

Presented By

Prof. Frank Behrens, Goethe-University & Fraunhofer ITMP, Germany

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:35

Low IL-18: a hidden culprit of long COVID in patients with autoimmune disease

Presented By

Dr Jeffrey Sparks, Brigham and Women's Hospital, MA, USA

Trial

RheumCARD

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:29

Stopping DMARDs? These key factors predict RA flares

Presented By

Dr Fiona Rayner, Newcastle University, UK

Trial

BIO-FLARE

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:27

How close are we to personalised medicine in psoriatic arthritis?

Presented By

Prof. Ennio Lubrano, University of Molise, Ital

Conference

IFPA 2024

Type

News article

17 July 2024 14:38

Using advances in the genetics of psoriatic disease to better predict treatment response

Presented By

Prof. Carl Goodyear, University of Glasgow, Scotland

Conference

IFPA 2024

Type

News article

17 July 2024 14:28

The unfavourable role of obesity in psoriatic disease

Presented By

Prof. Ulrich Mrowietz, University Medical Center Schleswig-Holstein, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:13

Managing obesity and fibromyalgia in psoriatic disease

Presented By

Prof. Philip Mease, University of Washington, USA

Conference

IFPA 2024

Type

News article

17 July 2024 14:08

Improving outcomes in pregnancy and psoriatic disease

Presented By

Dr Oseme Etomi, Guy's and St Thomas' Hospital, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:44

Towards prevention of psoriatic arthritis in patients with psoriasis

Presented By

Prof. Laura Coates, University of Oxford, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:39

Itch and pain are major components of psoriatic disease and require management

Presented By

Prof. Adam Reich; Dr Anushka Irani

Conference

IFPA 2024

Type

News article

17 July 2024 12:07

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

17 July 2024 11:55

Ixekizumab resolves nail psoriasis better than adalimumab in PsA

Presented By

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Trial

Phase 4, SPIRIT-H2H

Conference

ACR 2023

Type

News article

1 December 2023 12:36

Short-term glucocorticoid use increases the risk of MACE

Presented By

Dr Beth Wallace, University of Michigan, MI, USA

Conference

ACR 2023

Type

News article

1 December 2023 12:32

Positive efficacy and safety results of novel BlyS/APRIL inhibitor in RA

Presented By

Prof. Li Wang, Peking Union Medical College Hospital, China

Trial

Phase 3

Conference

ACR 2023

Type

News article

1 December 2023 12:27

Is split-dose methotrexate superior to single-dose methotrexate in RA?

Presented By

Dr Varun Dhir

Trial

SMART

Conference

ACR 2023

Type

News article

1 December 2023 12:11

IV secukinumab safe and effective for long-term treatment of active PsA

Presented By

Prof. Iain McInnes, University of Glasgow, Scotland

Trial

FUTURE 2-5

Conference

ACR 2023

Type

News article

1 December 2023 12:04

Apremilast in early oligoarticular PsA: phase 4 study results

Presented By

Dr Philip Mease, University of Washington, WS, USA

Trial

Phase 4, FOREMOST

Conference

ACR 2023

Type

News article

1 December 2023 12:03

Baricitinib superior to TNFi in patients with RA who failed csDMARDs

Presented By

Dr Mart van der Laar, University of Twente, The Netherlands

Trial

PerfectRA

Conference

ACR 2023

Type

News article

1 December 2023 11:40

Dual IL-17 blockade yields efficacy on joints and skin

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

Phase 3, BE OPTIMAL; BE COMPLETE

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 12:27

Strategies for Early Psoriatic Arthritis Recognition in Psoriasis Patients: GRAPPA Survey Findings

Trial

Review study, GRAPPA

20 October 2023 12:15

Therapy with biological DMARDs shows no correlation with fracture risk in RA

Presented By

Ms Ingebjorg Tronstad, Norwegian University of Science and Technology, Norway

Trial

HUNT

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:50

Bimekizumab: high rates of sustained response in PsA

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:46

Vascular inflammation may be characteristic of PsA

Presented By

Dr Nienke Kleinrensink, UMC Utrecht, the Netherlands

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:18

Obesity in PsA is increasingly affecting male patients

Presented By

Dr Marlene Stirnimann-Agustoni, University Hospital of Zürich, Switzerland

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:13

PsA patients: highest risk of developing NAFLD

Presented By

Mr Anthony Harrison, Leeds Teaching Hospitals NHS Trust, UK

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:09

Poly-refractory RA: not common, but still present

Presented By

Dr Paula David, University of Leeds, UK

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:04

COBRA-Slim bio-induction: no benefit compared with the standard regimen

Trial

CareRA2020

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:59

AI almost as successful as experts in predicting early RA

Presented By

Dr Yanli Li, Leiden University Center, the Netherlands

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:54

Disease activity-guided dose reduction may be a long-term option for stable RA

Presented By

Dr Noortje van Herwaarden, Sint Maartenskliniek, the Netherlands

Trial

DRESS

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:40

Cardiovascular safety of JAK inhibitors: reassuring results from a real-world study

Presented By

Mr Romain Aymon, Geneva University Hospital, Switzerland

Trial

ORAL Surveillance

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 00:00

Selective JAK1/TYK 2 inhibitor effective in patients with difficult-to-treat RA

Presented By

Prof. Xiaofeng Zeng, Peking Union Medical College Hospital, China

Conference

EULAR 2023

Type

Peer-reviewed article

30 July 2023 23:53

EULAR 2023 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2023

18 June 2023 22:24

Biologics in psoriasis: can they prevent joint involvement?

Presented By

Ms Kathleen Miao, Keck School of Medicine of USC, CA, USA

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 12:46

Glucocorticoids in rheumatic diseases: Is there a skeletal sparing dose?

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

ACR 2022

Type

News article

1 December 2022 14:37

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Presented By

Prof. Christopher Ritchlin, University of Rochester Medical Center, USA

Trial

Phase 3

Conference

ACR 2022

Type

News article

1 December 2022 14:33

Stimulation of PD-1: a new concept to treat RA

Presented By

Prof. Paul Emery, University of Leeds, UK

Trial

Phase 2

Conference

ACR 2022

Type

News article

1 December 2022 14:28

High retention rates after switching between infliximab biosimilars

Presented By

Dr Hafsah Nabi, Rigshospitalet, Denmar

Conference

ACR 2022

Type

News article

1 December 2022 14:21

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Presented By

Dr Sinead Magui, St. James’ Hospital, Ireland

Conference

ACR 2022

Type

News article

1 December 2022 14:12

Early treatment: a key to improved outcomes in polyarticular JIA

Presented By

Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA

Trial

STOP-JIA

Conference

ACR 2022

Type

News article

1 December 2022 12:23

No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies

Presented By

Dr Juan Molina Collada , Gregorio Marañón General University Hospital, Spain

Trial

BIOBADASER

Conference

ACR 2022

Type

News article

1 December 2022 12:03

Selective IL-23 inhibitor achieves long-term disease control in many patients with active PsA

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

KEEPsAKE 1; KEEPsAKE 2

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:28

AI machine learning algorithm useful in early detection of PsA

Presented By

Dr Jonathan Shapiro, Maccabi Healthcare Services, Israel

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:24

Novel biomarkers enable personalised medicine in early RA

Presented By

Dr Patrick Vandormael, Hasselt University, Belgium

Trial

CareRA

Conference

BCR 2022

23 September 2022 13:42

TARDIS-RA suggests choosing IL-6 inhibitors after JAK inhibitor failure

Presented By

Dr Diederik De Cock, KU Leuven, Belgium

Trial

TARDIS-RA

Conference

BCR 2022

23 September 2022 13:37

Rheumatoid arthritis-associated ILD

Presented By

Dr Phuong Phuong Diep, Oslo University Hospital, Norway

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:22

Thoracic ultrasound: a new diagnostic imaging tool in RA-ILD?

Presented By

Dr Bjørk Sofíudóttir, University of South Denmark, Denmark

Trial

AURORA

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:19

How to treat enthesitis in 2022

Presented By

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Trial

Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:42

Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib

Presented By

Prof. Lars Erik Kristensen , Copenhagen University Hospital, Denmark

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:30

Treat-to-target dose reduction effective in spondyloarthritis

Presented By

Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:21

Many RA and PsA patients have problems with their sex life

Presented By

Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:12

Comorbid depression comes with a profoundly higher mortality risk in RA

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:10

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By

Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands

Trial

TREAT EARLIER

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:07

Risk factors for dementia in RA patients discovered

Presented By

Prof. Elena Myasoedova , Mayo Clinic, MN, USA

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:02

EULAR 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2022

22 June 2022 23:51

Gene profiling may predict treatment response in refractory rheumatoid arthritis

Journal

Nature Medicine

3 June 2022 21:22

JAK inhibitors: A risk assessment

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 10:59

Methotrexate plus leflunomide a treatment option for psoriatic arthritis

Journal

The Lancet Rheumatology

18 March 2022 19:53

Coal mining, silica dust associated with rheumatoid arthritis in Appalachia

Journal

Occupational & Environmental Medicine

8 February 2022 18:27

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By

Dr Charlie Bridgewood, University of Leeds, UK

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 10:51

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:22

Selective IL-23 inhibition normalises gene expression in active PsA

Presented By

Ms Michelle Miron

Trial

Phase 3, DISCOVER-1&-2

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 13:48

Cancer risk up 48% when tofacitinib given for arthritis

Journal

The New England Journal of Medicine

26 January 2022 23:00

Zinc may worsen rheumatoid arthritis, lab study suggests

Journal

Science Signaling

18 January 2022 22:26

Risankizumab effective against refractory psoriatic arthritis

Journal

BMJ Annals of the Rheumatic Diseases

17 January 2022 17:15

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By

Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain

Trial

JAK-pot

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:03

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By

Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 11:01

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By

Prof. Joshua J. Solomon, National Jewish Health, CO, USA

Trial

Phase 2, TRAIL1

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:59

Ultra-low dosing of rituximab in RA is a viable treatment option

Presented By

Mr Nathan den Broeder, Sint Maartenskliniek, the Netherlands

Trial

REDO

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:58

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By

Dr April Jorge, Massachusetts General Hospital, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:55

More pros than cons for the use of statins in RA

Presented By

Dr Gulsen Ozen, University of Nebraska Medical Center, NE, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:54

Selective IL-23 inhibition: a new option in active PsA

Presented By

Prof. Andrew Östör, Monash University, Australia

Trial

Phase 3, KEEPsAKE 1, KEEPsAKE 2

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:52

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By

Dr Michaela Köhm, Goethe-University Frankfurt, Germany

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:48

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By

Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By

Prof. Jean Liew, Boston University, MA, USA

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By

Dr Inés Colmegna, McGill University Health Centre, Canada

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:06

PFGC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

PFGC 2021

22 December 2021 08:12

Support for therapeutic drug monitoring with infliximab maintenance therapy

Journal

JAMA

21 December 2021 17:19

Immune-mediated diseases tied to risk of cancer

Journal

JAMA Oncology

9 December 2021 21:17

Guselkumab boosts response in resistant psoriatic arthritis

Journal

Annals of the Rheumatic Diseases

30 November 2021 21:21

ACR 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ACR 2021

22 November 2021 16:18

Two-dose COVID-19 vaccination may not lead to flares in RA patients

Journal

Annals of the Rheumatic Diseases

3 November 2021 16:50

Support for TNF-inhibitor monotherapy in COVID patients with RA and related diseases

Journal

JAMA Network Open

18 October 2021 22:36

B-cell-targeted therapy linked with severe COVID-19 among patients with arthritis

Journal

Annals of the Rheumatic Diseases

8 October 2021 16:02

Pausing mycophenolate boosts COVID-19-vaccine response in patients with rheumatic and musculoskeletal diseases

Journal

Annals of the Rheumatic Diseases

30 September 2021 17:08

Live varicella-zoster vaccine safe, effective with TNF inhibitors

Journal

Annals of Internal Medicine

29 September 2021 23:18

Could steroid treatment speed recovery from infliximab-induced liver injury?

Journal

Journal of Hepatology

28 September 2021 17:12

Oral CBD fails to relieve pain from hand osteoarthritis, psoriatic arthritis, but questions linger

Journal

Pain

20 September 2021 19:15

Unresolved needs for patients with PsA despite growing therapeutic options

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:46

Bridging the gap between patients and access to psoriasis specialists

Presented By

Dr Silvia Fernandez Barrio, AEPSO, Argentina

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:42

Psoriasis and PsA in transgender adults on hormone therapy

Presented By

Ms Julia Gao, Fenway Health, MA, USA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:41

Active PsA: Biomarkers distinguish radiographic progressors from non-progressors

Trial

Phase 3, SPIRIT-P1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:37